首页> 外文期刊>Neurosurgery >Treatment of giant and large internal carotid artery aneurysms with a high-flow replacement bypass using the excimer laser-assisted nonocclusive anastomosis technique.
【24h】

Treatment of giant and large internal carotid artery aneurysms with a high-flow replacement bypass using the excimer laser-assisted nonocclusive anastomosis technique.

机译:使用准分子激光辅助的非闭塞性吻合技术,通过高流量置换旁路治疗巨大而大型的颈内动脉瘤。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To define the clinical value of the high-flow replacement bypass using the excimer laser-assisted nonocclusive anastomosis technique in the treatment of patients with a noncoilable, nonclippable giant or large intracranial aneurysm of the internal carotid artery (ICA). METHODS: We studied 34 patients with a giant intracranial aneurysm of the ICA proximal to its bifurcation who were treated with an extracranial-intercranial high-flow replacement bypass in our hospital between 1999 and 2004. We retrospectively collected data for patient characteristics, operative aspects, complications, and functional health scores using the modified Rankin scale. Long-term data were updated by questionnaire and telephone survey. Mean long-term follow-up period was 3.3 years (range, 0.6-5.6 yr). RESULTS: We were able to construct a patent bypass in 33 out of 34 patients (97%). In six patients (17%), we needed two bypass attempts. In one patient (3%), the bypass was technically impossible. After bypass construction, we occluded the ICA during or after surgery in 32 patients (94%), causing aneurysm thrombosis in all of these patients. A fatal complication occurred in two patients (6%) before we could occlude the ICA. A nonfatal complication occurred in seven patients (21%). In the long term, 25 patients (74%) had a favorable outcome and 27 patients (79%) were independent (modified Rankin scale, <3). CONCLUSION: This study shows that the excimer laser-assisted nonocclusive anastomosis high-flow replacement bypass, which provides maximum brain protection because of its nonocclusive character, is a reliable and effective method to treat these otherwise untreatable patients.
机译:目的:利用准分子激光辅助的非闭塞性吻合技术确定高流量置换旁路术在治疗颈内动脉(ICA)不可缠绕,不可卡住的巨大或大型颅内动脉瘤的患者中的临床价值。方法:我们研究了1999年至2004年间在我院分叉处发生的ICA靠近颅内分支的巨大颅内动脉瘤的34例患者,这些患者均经过颅外-高流量置换术治疗。我们回顾性收集了患者特征,手术方面的数据,并发症,以及使用改良的Rankin量表的功能健康评分。通过问卷调查和电话调查更新了长期数据。平均长期随访期为3.3年(范围0.6-5.6年)。结果:我们能够在34位患者中的33位(97%)中建立专利旁路。在六名患者(17%)中,我们需要进行两次旁路尝试。一名患者(3%)在技术上无法进行旁路。经过旁路建造后,我们在32例患者中(94%)在手术期间或术后封堵了ICA,导致所有这些患者的动脉瘤血栓形成。在我们阻塞ICA之前,有两名患者(6%)发生了致命并发症。 7例患者(21%)发生了非致命性并发症。从长远来看,有25例患者(74%)有良好的预后,而27例患者(79%)是独立的(改良兰金量表,<3)。结论:这项研究表明,准分子激光辅助非阻塞吻合术高流量置换旁路由于其非阻塞特性而可提供最大程度的大脑保护,是治疗这些原本无法治疗的患者的可靠有效方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号